From Wikipedia:
Studies that are in vivo (Latin for
From Wikipedia:
Studies that are in vivo (Latin for "within the living"; often not italicized in English) are those in which the effects of various biological entities are tested on whole, living organisms or cells, usually animals, including humans, and plants, as opposed to a tissue extract or dead organism...
I assume that because it was tested with live virus cells. Such an exciting set of results!! Lots of great momentum for a strong IPO. This gives great credibility to both the process GNBT/NGIO has taken as well as the leadership Joe has shown to be patient and disciplined. Congratulations and keep it going
1
Generex Biotechnology Corp. (GNBTQ) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Top 5 Most Recently Viewed Articles
Vishay Intertechnology's Quarterly Dividend Announcement Vishay Intertechnology, Inc. (NYSE: VSH), a global leader in the manufacturing of discrete semiconductors and passive components, has recently made headlines by declaring a quarterly dividend. This announcement marks a significant moment for the company and its stakeholders as it reflects the steady financial health...
Continue Reading
Most discussions about recession-resistant business categories focus on the obvious choices: healthcare, essential retail, waste management, and food. What rarely comes up, despite being one of the cleaner examples of a service with demand that genuinely does not shrink during economic downturns, is commercial energy management. Specifically, the energy brokerage model is...
Continue Reading
Stephens Upgrades Guaranty Bancshares' Price Target Recently, Stephens announced an increase in its target price for Guaranty Bancshares, Inc. (NYSE: GNTY) to $40.00. This updated estimation is an advancement from the previous target of $38.00. The positive adjustment comes after the company reported strong third-quarter earnings per share (EPS), which exceeded analysts'...
Continue Reading
Lightwave Logic's Upcoming Special Call Announcement Lightwave Logic, Inc. (NASDAQ: LWLG) has exciting news to share as it prepares to host a special call on March 13, 2025. This event aims to shed light on the industry applications of electro-optic polymers, the company’s competitive positioning, and its strategic approach to market penetration. What to Expect from the...
Continue Reading
Innovative Partnership Between ONCare Alliance and Ovation.io The ONCare Alliance and Ovation.io have embarked on an exciting collaboration to develop a multi-omics database and biobank aimed at accelerating biomarker discovery in the oncology field. This partnership combines the expertise of 32 independent oncology practices represented by ONCare with Ovation.io, a...
Continue Reading
